Conclusion: Qining Injection could alleviate the symptoms,improve the quality of life,increase the weight,improve the immunity and stabilize the tumor in the medium or late stage NSCLC patients.
结论:奇宁注射液能够缓解中晚期非小细胞肺癌患者临床症状,改善患者生存质量,增加体重,稳定瘤体,提高免疫力,延缓肺癌的发展和转移。
参考来源 - 奇宁注射液治疗中晚期非小细胞肺癌的临床与实验研究·2,447,543篇论文数据,部分数据来源于NoteExpress
应用推荐